1-3 of 3
Ming Yao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK–Mediated Phosphorylation of Akt

Free
Naitao Wang, Ming Yao, Jin Xu, Yizhou Quan, Kaiqing Zhang, Ru Yang, Wei-Qiang Gao
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (20): 4676–4685.
https://doi.org/10.1158/1078-0432.CCR-14-3163
Published: 14 October 2015
View article titled, Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK–Mediated Phosphorylation of Akt
Open the PDF for Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK–Mediated Phosphorylation of Akt in another window
Includes: Supplementary data
Journal Articles

The autocrine sPDZD2 protein is a potential p53 activator

Free
Chun Tam, Vincent Liu, Wai Leung, Kwok-Ming Yao, Stephen Shiu
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22_Supplement): B40.
Published: 15 August 2014
View article titled, The autocrine sPDZD2 protein is a potential p53 activator
Journal Articles

Characterization of CEBPA Mutations in Acute Myeloid Leukemia: Most Patients with CEBPA Mutations Have Biallelic Mutations and Show a Distinct Immunophenotype of the Leukemic Cells

Free
Liang-In Lin, Chien-Yuan Chen, Dong-Tsamn Lin, Woei Tsay, Jih-Luh Tang, You-Chia Yeh, Hwei-Ling Shen, Fang-Hsien Su, Ming Yao, Sheng-Yi Huang, Hwei-Fang Tien
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1372–1379.
https://doi.org/10.1158/1078-0432.CCR-04-1816
Published: 02 March 2005
View article titled, Characterization of CEBPA Mutations in Acute Myeloid Leukemia: Most Patients with CEBPA Mutations Have Biallelic Mutations and Show a Distinct Immunophenotype of the Leukemic Cells
Open the PDF for Characterization of CEBPA Mutations in Acute Myeloid Leukemia: Most Patients with CEBPA Mutations Have Biallelic Mutations and Show a Distinct Immunophenotype of the Leukemic Cells in another window